{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T21:36:49Z","timestamp":1782423409079,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lipofuscin deposition is a characteristic manifestation of aging. There is very limited literature in humans and in animals describing these deposits in native kidneys. Overall, it is thought to be non-pathogenic and successful transplants from a donor with lipofuscin deposits have been reported. We present the case of a patient who underwent a kidney transplant and a for-cause biopsy post-transplantation incidentally revealed lipofuscin deposition.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 48-year old gentleman with a past medical history of diabetes, hypertension, coronary artery disease, and ischemic and then hemorrhagic cardiovascular accident underwent a successful kidney transplant. His donor was an expanded criteria donor with no major past medical history. Post-transplant course was complicated by delayed graft function requiring one dialysis treatment for hyperkalemia. After that he had an uneventful course and achieved a baseline creatinine of 1.2\u2009mg\/dL, with no proteinuria. On a routine 19-month follow-up he was noted to have proteinuria and an antibody against the major-histocompatibility-complex class I-related chain A. A graft biopsy revealed acute antibody-mediated rejection and impressive lipofuscin deposition. He was subsequently treated with an antibody-mediated rejection protocol that included high dose steroids, Rituximab, plasmapheresis, and intravenous immunoglobulin, but responded poorly to this regimen. A 6-month follow up biopsy continued to show lipofuscin deposition, with similar microvascular injury scores and 12-months later his creatinine remained stable but his proteinuria worsened. Patient was struggling with recurrent infectious episodes requiring hospitalizations and thus no further diagnostic or therapeutic treatments were pursued.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Lipofuscin deposition has been reported in solid organ transplants but the significance and cause are not well understood. Several physiologic and some pathologic causes to these deposits have been reported including age, diabetes, medications and a genetic syndrome. We propose that immunologic causes such as rejection in the presence of other risk factors could potentiate the oxidative stress leading to excessive lipofuscin deposition in kidney transplants. In the case of our patient, we conclude that these deposits were likely recipient-derived, and postulate that the cumulative burden of inflammation from rejection, and underlying medical conditions led to increased lipofuscin deposition. We speculate them to be an innocent bystander.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-019-1569-6","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T14:59:24Z","timestamp":1571324364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A case report on lipofuscin deposition in a graft biopsy two years after kidney transplantation: an insignificant bystander or a pathogenic benefactor?"],"prefix":"10.1186","volume":"20","author":[{"given":"Vivian W. Y.","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-Jeanne","family":"Pilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre O.","family":"Fiset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1941-0598","authenticated-orcid":false,"given":"Shaifali","family":"Sandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,17]]},"reference":[{"issue":"2","key":"1569_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1699-0463.1998.tb01346.x","volume":"106","author":"A Terman","year":"1998","unstructured":"Terman A, Brunk UT. Lipofuscin: mechanisms of formation and increase with age. Apmis. 1998;106(2):265\u201376.","journal-title":"Apmis."},{"issue":"3","key":"1569_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0190-9622(85)70079-5","volume":"12","author":"A Alinovi","year":"1985","unstructured":"Alinovi A, Reverberi C, Melissari M, Gabrielli M. Cutaneous hyperpigmentation induced by amiodarone hydrochloride. J Am Acad Dermatol. 1985;12(3):563\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"1569_CR3","first-page":"287","volume":"47","author":"C Biava","year":"1965","unstructured":"Biava C, West M. Lipofuscin-like granules in vascular smooth muscle and juxtaglomerular cells of human kidneys. Am J Pathol. 1965;47:287\u2013313.","journal-title":"Am J Pathol"},{"issue":"3\u20134","key":"1569_CR4","doi-asserted-by":"publisher","first-page":"E282","DOI":"10.5489\/cuaj.1207","volume":"8","author":"A Yarmohamadi","year":"2014","unstructured":"Yarmohamadi A, Rezayat AR, Memar B, Rahimi HR, Cand P. Normal black kidney. Can Urol Assoc J. 2014;8(3\u20134):E282\u20136.","journal-title":"Can Urol Assoc J"},{"issue":"5","key":"1569_CR5","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4161\/auto.6259","volume":"4","author":"RA Nixon","year":"2008","unstructured":"Nixon RA, Yang DS, Lee JH. Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy. 2008;4(5):590\u20139.","journal-title":"Autophagy."},{"issue":"1","key":"1569_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jtcvs.2009.02.040","volume":"138","author":"M Zakliczynski","year":"2009","unstructured":"Zakliczynski M, Nozynski J, Konecka-Mrowka D, Krynicka-Mazurek A, Swierad M, Maruszewski M, et al. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy? J Thorac Cardiovasc Surg. 2009;138(1):215\u201321 21.e1\u20133.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1569_CR7","unstructured":"Suvarna SK, In Layton, C., & In Bancroft, J. D. . Bancroft's theory and practice of histological techniques. 7th ed: Elsevier; 2018."},{"issue":"5","key":"1569_CR8","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.transproceed.2019.03.017","volume":"51","author":"Y Kawaguchi","year":"2019","unstructured":"Kawaguchi Y, Oguchi H, Mikami T, Yamaguchi Y, Ohashi Y, Kawamura T, et al. Can Lipofuscin deposition on renal allograft tubular epithelium be a surrogate marker for kidney allograft aging? Transplant Proc. 2019;51(5):1343\u20137.","journal-title":"Transplant Proc"},{"key":"1569_CR9","doi-asserted-by":"publisher","first-page":"324916","DOI":"10.4061\/2011\/324916","volume":"2011","author":"R Gordillo","year":"2011","unstructured":"Gordillo R, Del Rio M, Thomas DB, Flynn JT, Woroniecki RP. Hypertension, chronic kidney disease, and renal pathology in a child with hermansky-pudlak syndrome. Int J Nephrol. 2011;2011:324916.","journal-title":"Int J Nephrol"},{"issue":"18","key":"1569_CR10","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1056\/NEJM199804303381803","volume":"338","author":"WA Gahl","year":"1998","unstructured":"Gahl WA, Brantly M, Kaiser-Kupfer MI, Iwata F, Hazelwood S, Shotelersuk V, et al. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). N Engl J Med. 1998;338(18):1258\u201364.","journal-title":"N Engl J Med"},{"key":"1569_CR11","doi-asserted-by":"crossref","unstructured":"Abdullah N, Davis NF, Quinn J, Mohan P. Living donor renal transplant in a patient with end-stage renal disease due to Hermansky-Pudlak syndrome. BMJ Case Rep. 2018;2018.","DOI":"10.1136\/bcr-2017-223376"},{"issue":"2","key":"1569_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.prp.2010.11.002","volume":"207","author":"M Bisceglia","year":"2011","unstructured":"Bisceglia M, Carosi I, D'Errico M, Di Giorgio G, Castagnoli A, Pasquinelli G. Lipofuscin-like granules of the juxtaglomerular apparatus of the kidney. The diagnostic significance of a quasi-normal subcellular structure incidentally encountered in the course of routine ultrastructural evaluation of renal biopsies. Pathol Res Pract. 2011;207(2):79\u201385.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"1569_CR13","first-page":"21","volume":"60","author":"B Chmiel","year":"2003","unstructured":"Chmiel B, Kusmierski S, Kokocinska D, Cierpka L. Serum lipofuscin level after renal transplantation. Przegl Lek. 2003;60(1):21\u20133.","journal-title":"Przegl Lek"},{"issue":"5","key":"1569_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/15513818909026908","volume":"9","author":"BH Landing","year":"1989","unstructured":"Landing BH, Gonick HC, Nadorra RL, Hyman CB, Wells TR, Villarreal-Engelhardt G, et al. Renal lesions and clinical findings in thalassemia major and other chronic anemias with hemosiderosis. Pediatr Pathol. 1989;9(5):479\u2013500.","journal-title":"Pediatr Pathol"},{"issue":"1","key":"1569_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3177\/jnsv.37.99","volume":"37","author":"K Hagiwara","year":"1991","unstructured":"Hagiwara K, Naito K, Kurokawa Y, Ichikawa T. Kidney injury induced by lipid peroxide produced by vitamin E deficiency and GSH depletion in rats. J Nutr Sci Vitaminol (Tokyo). 1991;37(1):99\u2013107.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"1","key":"1569_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archdermatol.2007.25","volume":"144","author":"A Ammoury","year":"2008","unstructured":"Ammoury A, Michaud S, Paul C, Prost-Squarcioni C, Alvarez F, Lamant L, et al. Photodistribution of blue-gray hyperpigmentation after amiodarone treatment: molecular characterization of amiodarone in the skin. Arch Dermatol. 2008;144(1):92\u20136.","journal-title":"Arch Dermatol"},{"issue":"4","key":"1569_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0190-9622(87)70101-7","volume":"16","author":"S Waitzer","year":"1987","unstructured":"Waitzer S, Butany J, From L, Hanna W, Ramsay C, Downar E. Cutaneous ultrastructural changes and photosensitivity associated with amiodarone therapy. J Am Acad Dermatol. 1987;16(4):779\u201387.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1569_CR18","first-page":"131","volume":"21","author":"A Stacchiotti","year":"2006","unstructured":"Stacchiotti A, Rodella LF, Ricci F, Rezzani R, Lavazza A, Bianchi R. Stress proteins expression in rat kidney and liver chronically exposed to aluminium sulphate. Histol Histopathol. 2006;21(2):131\u201340.","journal-title":"Histol Histopathol"},{"issue":"4","key":"1569_CR19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000168854","volume":"15","author":"SK Jain","year":"1995","unstructured":"Jain SK, Abreo K, Duett J, Sella ML. Lipofuscin products, lipid peroxides and aluminum accumulation in red blood cells of hemodialyzed patients. Am J Nephrol. 1995;15(4):306\u201311.","journal-title":"Am J Nephrol"},{"key":"1569_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archinte.1964.00280090064011","volume":"113","author":"AH Rubenstein","year":"1964","unstructured":"Rubenstein AH, Abrahams C, Stables DP, Levin NW. Acetophenetidin nephritis and papillary necrosis: a clinical and pathological study of six cases. Arch Intern Med. 1964;113:378\u201394.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1569_CR21","first-page":"99","volume":"99","author":"ZL Hegedus","year":"1991","unstructured":"Hegedus ZL, Nayak U. Para-aminophenol and structurally related compounds as intermediates in lipofuscin formation and in renal and other tissue toxicities. Arch Int Physiol Biochim Biophys. 1991;99(1):99\u2013105.","journal-title":"Arch Int Physiol Biochim Biophys"},{"issue":"4","key":"1569_CR22","first-page":"353","volume":"82","author":"C Harris","year":"1966","unstructured":"Harris C. A lipofuscin-like pigment in the kidneys of estrogen-treated rats. Arch Pathol. 1966;82(4):353\u20135.","journal-title":"Arch Pathol"},{"issue":"1","key":"1569_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00007890-198707000-00039","volume":"44","author":"AJ Mocelin","year":"1987","unstructured":"Mocelin AJ, Brandina L, Fraga AM, Gordan PA, Bergonse MR, Matni AM, et al. A blue kidney in a living donor. Transplantation. 1987;44(1):169.","journal-title":"Transplantation."},{"issue":"2","key":"1569_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/ajt.14625","volume":"18","author":"M Haas","year":"2018","unstructured":"Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, et al. The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant. 2018;18(2):293\u2013307.","journal-title":"Am J Transplant"},{"issue":"7","key":"1569_CR25","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/liv.13753","volume":"38","author":"AC Croce","year":"2018","unstructured":"Croce AC, Ferrigno A, Bottiroli G, Vairetti M. Autofluorescence-based optical biopsy: an effective diagnostic tool in hepatology. Liver Int. 2018;38(7):1160\u201374.","journal-title":"Liver Int"},{"key":"1569_CR26","volume-title":"Bancroft's theory and practice of histological techniques: Elsevier","author":"K Suvarna","year":"2018","unstructured":"Suvarna K, Layton C, Bancroft J. Bancroft's theory and practice of histological techniques: Elsevier; 2018."},{"issue":"1","key":"1569_CR27","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.4081\/ejh.2015.2485","volume":"59","author":"G Di Guardo","year":"2015","unstructured":"Di Guardo G. Lipofuscin, lipofuscin-like pigments and autofluorescence. Eur J Histochem. 2015;59(1):2485.","journal-title":"Eur J Histochem"},{"issue":"2","key":"1569_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5858\/arpa.2011-0689-RA","volume":"137","author":"C Melin","year":"2013","unstructured":"Melin C, Miick R, Young NA, Ortiz J, Balasubramanian M. Approach to intraoperative consultation for donor liver biopsies. Arch Pathol Lab Med. 2013;137(2):270\u20134.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"1569_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41100-019-0199-6","volume":"5","author":"T Yagisawa","year":"2019","unstructured":"Yagisawa T, Mieno M, Ichimaru N, Morita K, Nakamura M, Hotta K, et al. Trends of kidney transplantation in Japan in 2018: data from the kidney transplant registry. Ren Replace Ther. 2019;5(1):3.","journal-title":"Ren Replace Ther"},{"issue":"3","key":"1569_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cardiores.2005.08.014","volume":"68","author":"A Terman","year":"2005","unstructured":"Terman A, Brunk UT. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res. 2005;68(3):355\u201365.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"1569_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.carpath.2011.11.002","volume":"21","author":"SJ Parson","year":"2012","unstructured":"Parson SJ, Russell SD, Bennett MK, Dunn JM, Gilotra NA, Rao S, et al. Increased lipofuscin on endomyocardial biopsy predicts greater cardiac improvement in adolescents and young adults. Cardiovasc Pathol. 2012;21(4):317\u201323.","journal-title":"Cardiovasc Pathol"},{"issue":"13","key":"1569_CR32","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa067160","volume":"357","author":"Y Zou","year":"2007","unstructured":"Zou Y, Stastny P, S\u00fcsal C, D\u00f6hler B, Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med. 2007;357(13):1293\u2013300.","journal-title":"N Engl J Med"},{"issue":"5357","key":"1569_CR33","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1126\/science.279.5357.1737","volume":"279","author":"V Groh","year":"1998","unstructured":"Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial \u03b3\u03b4 T cells. Science. 1998;279(5357):1737\u201340.","journal-title":"Science."},{"issue":"2","key":"1569_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00262-009-0752-1","volume":"59","author":"B Li","year":"2010","unstructured":"Li B, Lei Z, Lichty BD, Li D, Zhang GM, Feng ZH, et al. Autophagy facilitates major histocompatibility complex class I expression induced by IFN-gamma in B16 melanoma cells. Cancer Immunol Immunother. 2010;59(2):313\u201321.","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"1569_CR35","first-page":"357","volume":"5","author":"M Nafar","year":"2011","unstructured":"Nafar M, Sahraei Z, Salamzadeh J, Samavat S, Vaziri ND. Oxidative stress in kidney transplantation: causes, consequences, and potential treatment. Iran J Kidney Dis. 2011;5(6):357\u201372.","journal-title":"Iran J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1569-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1569-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1569-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T23:22:10Z","timestamp":1602804130000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1569-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,17]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1569"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1569-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,17]]},"assertion":[{"value":"14 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not indicated as this case report only includes pathology images that are entirely unidentifiable and there are no significant details on the individual whose case is presented.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s guardians for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Sandal has received an education grant from Amgen to increase living donor kidney transplantation. Dr. Fiset has received honoraria from Pfizer Canada, Merck Canada and AstraZeneca Canada. Otherwise, the authors have no other relevant financial interests or conflict of interests to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"376"}}